| 拜复乐治疗社区获得性肺炎68例疗效分析 |
| |
| 引用本文： | 廖鸥飞,李卓庶. 拜复乐治疗社区获得性肺炎68例疗效分析[J]. 基层医学论坛, 2007, 0(7) |
| |
| 作者姓名： | 廖鸥飞 李卓庶 |
| |
| 作者单位： | 化州市人民医院 广东化州525100 |
| |
| 摘 要： | 目的评价分析拜复乐治疗社区获得性肺炎的疗效。方法对68例社区获得性肺炎患者,予拜复乐“莫西沙星”(德国拜耳公司)400mg,静脉滴注,每日1次,疗程7d～10d。结果临床有效率为92.7%,细菌清除率为85.5%,药物不良反应发生率为4.4%。结论拜复乐安全有效,是目前治疗社区获得性肺炎的理想药物。
|
| 关 键 词： | 莫西沙星 社区获得性肺炎 疗效 |
Effection of Moxifloxacin on 68 cases of community-acquired pneumonia |
| |
| Liao Oufei,Li Zhouzhe. Effection of Moxifloxacin on 68 cases of community-acquired pneumonia[J]. Public Medical Forum Magazine, 2007, 0(7) |
| |
| Authors: | Liao Oufei Li Zhouzhe |
| |
| Affiliation: | Liao Oufei,Li Zhouzhe. The peoples' hospital of Huazhou city . Huazhou,Guangdong 525100 |
| |
| Abstract: | Objective To evaluated the efficacy of moxifloxacin on community-acquired pneumonia. Methods 68 patients with community-acquired pneumonia were given moxifloxacin 400mg by intravenous infusion Qd. All patients had been treated for 7-14 days. Results The overall clinical effective rate was 92.7% and the bacterium clearance rate was 85.5%. The adverse effect incidence rate was 4.4%. Conclusion Moxifloxacin intravenous infusion is effective and safe for community-acquired pneumonia. |
| |
| Keywords: | Moxifloxacin Community-acquired pneumonia Curative effect |
| 本文献已被 CNKI 等数据库收录！ |
|
